Corvus hawaiiensis isolate bCorHaw1 chromosome 25, bCorHaw1.pri.cur, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Passeriformes; Corvoidea; Corvidae; Corvus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM036370.1.\nAssembly name: bCorHaw1.pri.cur\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/11/04. The original whole-genome shotgun project has the\naccession JAJGSY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 20-SEP-2021\nAssembly Method :: HiFiasm v. 0.15.4+galaxy; purge_dups v.\n 1.2.5+galaxy3; Bionano Solve v.\n 3.6.1+galaxy2; Salsa v. 2.3+galaxy0;\n gEVAL manual curation v. 2021-09-20; VGP\n pipeline v. 2.0\nAssembly Name :: bCorHaw1.pri.cur\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 29.61x\nSequencing Technology :: PacBio Sequel II HiFi; Illumina NovaSeq;\n Bionano Genomics Saphyr DLS; Arima\n Genomics Hi-C v2\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Corvus hawaiiensis Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
spermatogenesis-associated protein 16-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein DDB_G0271670-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 84% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ST14 transmembrane serine protease matriptase, transcript variant X8
COORDINATES: polyA evidence [ECO:0006239]
ST14 transmembrane serine protease matriptase, transcript variant X7
ST14 transmembrane serine protease matriptase, transcript variant X6
ST14 transmembrane serine protease matriptase, transcript variant X5
ST14 transmembrane serine protease matriptase, transcript variant X4
ST14 transmembrane serine protease matriptase, transcript variant X3
ST14 transmembrane serine protease matriptase, transcript variant X2
ST14 transmembrane serine protease matriptase, transcript variant X1
suppressor of tumorigenicity 14 protein isoform X5
suppressor of tumorigenicity 14 protein isoform X4
suppressor of tumorigenicity 14 protein isoform X3
suppressor of tumorigenicity 14 protein isoform X2
suppressor of tumorigenicity 14 protein isoform X1
suppressor of tumorigenicity 14 protein isoform X6
nuclear factor related to kappaB binding protein, transcript variant X2
nuclear factor related to kappaB binding protein, transcript variant X1
nuclear factor related to kappaB binding protein, transcript variant X3
nuclear factor related to kappa-B-binding protein isoform X2
nuclear factor related to kappa-B-binding protein isoform X1
nuclear factor related to kappa-B-binding protein isoform X3
PR domain zinc finger protein 10 isoform X4
PR domain zinc finger protein 10 isoform X3
PR domain zinc finger protein 10 isoform X2
PR domain zinc finger protein 10 isoform X1
amyloid beta precursor like protein 2, transcript variant X1
amyloid beta precursor like protein 2, transcript variant X2
amyloid beta precursor like protein 2, transcript variant X3
amyloid beta precursor like protein 2, transcript variant X4
amyloid beta precursor like protein 2, transcript variant X5
amyloid beta precursor like protein 2, transcript variant X6
amyloid beta precursor like protein 2 isoform X1
amyloid beta precursor like protein 2 isoform X2
amyloid beta precursor like protein 2 isoform X3
amyloid beta precursor like protein 2 isoform X4
amyloid beta precursor like protein 2 isoform X5
amyloid beta precursor like protein 2 isoform X6
uncharacterized LOC125338386, transcript variant X2
uncharacterized LOC125338386, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane protein 45B-like, transcript variant X1
transmembrane protein 45B-like, transcript variant X3
transmembrane protein 45B-like, transcript variant X4
transmembrane protein 45B-like, transcript variant X2
transmembrane protein 45B-like isoform X1
transmembrane protein 45B-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Rho GTPase activating protein 32, transcript variant X4
Rho GTPase activating protein 32, transcript variant X5
Rho GTPase activating protein 32, transcript variant X1
Rho GTPase activating protein 32, transcript variant X2
Rho GTPase activating protein 32, transcript variant X3
Rho GTPase activating protein 32, transcript variant X6
Rho GTPase activating protein 32, transcript variant X7
rho GTPase-activating protein 32 isoform X1
rho GTPase-activating protein 32 isoform X3
rho GTPase-activating protein 32 isoform X4
rho GTPase-activating protein 32 isoform X2
rho GTPase-activating protein 32 isoform X5
Rho GTPase activating protein 32, transcript variant X8
rho GTPase-activating protein 32 isoform X6
Rho GTPase activating protein 32, transcript variant X9
rho GTPase-activating protein 32 isoform X7
potassium inwardly rectifying channel subfamily J member 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
G protein-activated inward rectifier potassium channel 4 isoform X2
potassium inwardly rectifying channel subfamily J member 5, transcript variant X1
G protein-activated inward rectifier potassium channel 4 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium inwardly rectifying channel subfamily J member 1, transcript variant X2
potassium inwardly rectifying channel subfamily J member 1, transcript variant X1
ATP-sensitive inward rectifier potassium channel 1
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X2
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X1
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X3
Friend leukemia integration 1 transcription factor isoform X2
Friend leukemia integration 1 transcription factor isoform X1
Friend leukemia integration 1 transcription factor isoform X3
ETS proto-oncogene 1, transcription factor, transcript variant X3
ETS proto-oncogene 1, transcription factor, transcript variant X1
ETS proto-oncogene 1, transcription factor, transcript variant X2
kirre like nephrin family adhesion molecule 3, transcript variant X1
kirre like nephrin family adhesion molecule 3, transcript variant X2
kirre like nephrin family adhesion molecule 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X10
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X9
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X8
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X7
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X6
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X12
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X11
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X3
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X2
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X4
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X1
TIR domain containing adaptor protein, transcript variant X2
TIR domain containing adaptor protein, transcript variant X3
TIR domain containing adaptor protein, transcript variant X4
TIR domain containing adaptor protein, transcript variant X1
TIR domain containing adaptor protein, transcript variant X5
toll/interleukin-1 receptor domain-containing adapter protein
family with sequence similarity 118 member B, transcript variant X1
family with sequence similarity 118 member B, transcript variant X3
family with sequence similarity 118 member B, transcript variant X4
family with sequence similarity 118 member B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
family with sequence similarity 118 member B, transcript variant X2
signal recognition particle receptor subunit alpha
FAD dependent oxidoreductase domain containing 1
FAD-dependent oxidoreductase domain-containing protein 1
EI24 autophagy associated transmembrane protein
STT3 oligosaccharyltransferase complex catalytic subunit A, transcript variant X2
STT3 oligosaccharyltransferase complex catalytic subunit A, transcript variant X3
STT3 oligosaccharyltransferase complex catalytic subunit A, transcript variant X4
STT3 oligosaccharyltransferase complex catalytic subunit A, transcript variant X5
STT3 oligosaccharyltransferase complex catalytic subunit A, transcript variant X1
STT3 oligosaccharyltransferase complex catalytic subunit A, transcript variant X6
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A isoform X3
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A isoform X1
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A isoform X2
cell adhesion associated, oncogene regulated, transcript variant X2
cell adhesion associated, oncogene regulated, transcript variant X3
cell adhesion associated, oncogene regulated, transcript variant X1
cell adhesion molecule-related/down-regulated by oncogenes
V-set and immunoglobulin domain containing 10 like 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: V-set and immunoglobulin domain-containing protein 10-like 2
DEAD-box helicase 25, transcript variant X1
DEAD-box helicase 25, transcript variant X2
DEAD-box helicase 25, transcript variant X3
DEAD-box helicase 25, transcript variant X4
ATP-dependent RNA helicase DDX25 isoform X1
ATP-dependent RNA helicase DDX25 isoform X2
pseudouridine synthase 3, transcript variant X2
pseudouridine synthase 3, transcript variant X3
HYLS1 centriolar and ciliogenesis associated, transcript variant X1
HYLS1 centriolar and ciliogenesis associated, transcript variant X2
pseudouridine synthase 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
pseudouridine synthase 3, transcript variant X1
tRNA pseudouridine(38/39) synthase isoform X2
tRNA pseudouridine(38/39) synthase isoform X1
mitochondrial RNA pseudouridine synthase RPUSD4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
endothelial cell-selective adhesion molecule-like, transcript variant X3
endothelial cell-selective adhesion molecule-like, transcript variant X2
endothelial cell-selective adhesion molecule-like, transcript variant X1
endothelial cell-selective adhesion molecule-like isoform X1
endothelial cell-selective adhesion molecule-like isoform X2
Myb/SANT DNA binding domain containing 2, transcript variant X1
Myb/SANT DNA binding domain containing 2, transcript variant X7
Myb/SANT DNA binding domain containing 2, transcript variant X6
Myb/SANT DNA binding domain containing 2, transcript variant X4
Myb/SANT DNA binding domain containing 2, transcript variant X3
Myb/SANT DNA binding domain containing 2, transcript variant X5
Myb/SANT DNA binding domain containing 2, transcript variant X2
myb/SANT-like DNA-binding domain-containing protein 2 isoform X1
myb/SANT-like DNA-binding domain-containing protein 2 isoform X2
Myb/SANT DNA binding domain containing 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
myb/SANT-like DNA-binding domain-containing protein 2 isoform X3
Myb/SANT DNA binding domain containing 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
roundabout guidance receptor 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
roundabout guidance receptor 3, transcript variant X3
roundabout guidance receptor 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
roundabout guidance receptor 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
roundabout guidance receptor 3, transcript variant X5
roundabout guidance receptor 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
roundabout guidance receptor 3, transcript variant X7
roundabout guidance receptor 3, transcript variant X8
roundabout guidance receptor 4, transcript variant X11
roundabout guidance receptor 4, transcript variant X10
roundabout guidance receptor 4, transcript variant X4
roundabout guidance receptor 4, transcript variant X3
roundabout guidance receptor 4, transcript variant X9
roundabout guidance receptor 4, transcript variant X2
roundabout guidance receptor 4, transcript variant X8
roundabout guidance receptor 4, transcript variant X7
roundabout guidance receptor 4, transcript variant X6
roundabout guidance receptor 4, transcript variant X5
roundabout guidance receptor 4, transcript variant X1
hepatic and glial cell adhesion molecule
coiled-coil domain-containing protein 15
solute carrier family 37 member 2, transcript variant X2
solute carrier family 37 member 2, transcript variant X3
solute carrier family 37 member 2, transcript variant X5
solute carrier family 37 member 2, transcript variant X4
solute carrier family 37 member 2, transcript variant X1
glucose-6-phosphate exchanger SLC37A2 isoform X3
glucose-6-phosphate exchanger SLC37A2 isoform X4
glucose-6-phosphate exchanger SLC37A2 isoform X2
glucose-6-phosphate exchanger SLC37A2 isoform X1
transmembrane protein 218, transcript variant X2
transmembrane protein 218, transcript variant X1
transmembrane protein 218, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transmembrane protein 218, transcript variant X3
PBX/knotted 1 homeobox 2, transcript variant X5
PBX/knotted 1 homeobox 2, transcript variant X2
PBX/knotted 1 homeobox 2, transcript variant X4
PBX/knotted 1 homeobox 2, transcript variant X3
PBX/knotted 1 homeobox 2, transcript variant X1
PBX/knotted 1 homeobox 2, transcript variant X6
fasciculation and elongation protein zeta 1, transcript variant X1
fasciculation and elongation protein zeta 1, transcript variant X3
fasciculation and elongation protein zeta 1, transcript variant X2
fasciculation and elongation protein zeta-1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
zinc finger and BTB domain containing 44, transcript variant X1
zinc finger and BTB domain-containing protein 44 isoform X1
zinc finger and BTB domain containing 44, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 44 isoform X2
ADAM metallopeptidase with thrombospondin type 1 motif 8
A disintegrin and metalloproteinase with thrombospondin motifs 8
ADAM metallopeptidase with thrombospondin type 1 motif 15
A disintegrin and metalloproteinase with thrombospondin motifs 15
uncharacterized LOC125338377, transcript variant X5
uncharacterized LOC125338377, transcript variant X4
uncharacterized LOC125338377, transcript variant X3
uncharacterized LOC125338377, transcript variant X2
uncharacterized LOC125338377, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
opioid-binding protein/cell adhesion molecule homolog, transcript variant X4
opioid-binding protein/cell adhesion molecule homolog, transcript variant X3
opioid-binding protein/cell adhesion molecule homolog, transcript variant X6
opioid-binding protein/cell adhesion molecule homolog, transcript variant X5
opioid-binding protein/cell adhesion molecule homolog, transcript variant X2
opioid-binding protein/cell adhesion molecule homolog, transcript variant X1
opioid-binding protein/cell adhesion molecule homolog isoform X4
opioid-binding protein/cell adhesion molecule homolog isoform X3
opioid-binding protein/cell adhesion molecule homolog isoform X2
opioid-binding protein/cell adhesion molecule homolog isoform X1
opioid-binding protein/cell adhesion molecule homolog isoform X5
immunoglobulin superfamily member 9B, transcript variant X9
immunoglobulin superfamily member 9B, transcript variant X4
immunoglobulin superfamily member 9B, transcript variant X10
immunoglobulin superfamily member 9B, transcript variant X3
immunoglobulin superfamily member 9B, transcript variant X1
immunoglobulin superfamily member 9B, transcript variant X2
immunoglobulin superfamily member 9B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
immunoglobulin superfamily member 9B, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
immunoglobulin superfamily member 9B, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
immunoglobulin superfamily member 9B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
junctional adhesion molecule 3, transcript variant X2
junctional adhesion molecule 3, transcript variant X1
junctional adhesion molecule C isoform X1
junctional adhesion molecule C isoform X2
non-SMC condensin II complex subunit D3, transcript variant X2
non-SMC condensin II complex subunit D3, transcript variant X1
condensin-2 complex subunit D3 isoform X2
condensin-2 complex subunit D3 isoform X1
VPS26, retromer complex component B, transcript variant X3
VPS26, retromer complex component B, transcript variant X2
VPS26, retromer complex component B, transcript variant X1
vacuolar protein sorting-associated protein 26B isoform X1
vacuolar protein sorting-associated protein 26B isoform X2
VPS26, retromer complex component B, transcript variant X4
vacuolar protein sorting-associated protein 26B isoform X3
thymocyte nuclear protein 1, transcript variant X1
thymocyte nuclear protein 1, transcript variant X2
acyl-CoA dehydrogenase family member 8, transcript variant X1
acyl-CoA dehydrogenase family member 8, transcript variant X3
acyl-CoA dehydrogenase family member 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
isobutyryl-CoA dehydrogenase, mitochondrial isoform X1
isobutyryl-CoA dehydrogenase, mitochondrial isoform X3
isobutyryl-CoA dehydrogenase, mitochondrial isoform X2
galactosidase beta 1 like 2, transcript variant X1
galactosidase beta 1 like 2, transcript variant X2
galactosidase beta 1 like 2, transcript variant X3
galactosidase beta 1 like 2, transcript variant X4
beta-galactosidase-1-like protein 2 isoform X1
beta-galactosidase-1-like protein 2 isoform X2
beta-galactosidase-1-like protein 2 isoform X3
beta-galactosidase-1-like protein 2 isoform X4
beta-1,3-glucuronyltransferase 1, transcript variant X4
beta-1,3-glucuronyltransferase 1, transcript variant X2
beta-1,3-glucuronyltransferase 1, transcript variant X1
beta-1,3-glucuronyltransferase 1, transcript variant X5
beta-1,3-glucuronyltransferase 1, transcript variant X3
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X5
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X4
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X2
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X1
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X3
SCO-spondin-like, transcript variant X11
SCO-spondin-like, transcript variant X10
SCO-spondin-like, transcript variant X12
SCO-spondin-like, transcript variant X15
SCO-spondin-like, transcript variant X18
SCO-spondin-like, transcript variant X14
SCO-spondin-like, transcript variant X17
SCO-spondin-like, transcript variant X16
SCO-spondin-like, transcript variant X19
SCO-spondin-like, transcript variant X13
chromosome 25 CXorf65 homolog, transcript variant X1
chromosome 25 CXorf65 homolog, transcript variant X2
uncharacterized protein CXorf65 homolog isoform X1
uncharacterized protein CXorf65 homolog isoform X2
ATPase H+/K+ transporting non-gastric alpha2 subunit
potassium-transporting ATPase alpha chain 2
sodium voltage-gated channel beta subunit 3
PHD finger-like domain-containing protein 5A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
GRAM domain containing 1B, transcript variant X2
GRAM domain containing 1B, transcript variant X4
GRAM domain containing 1B, transcript variant X5
GRAM domain containing 1B, transcript variant X3
GRAM domain containing 1B, transcript variant X7
GRAM domain containing 1B, transcript variant X6
GRAM domain containing 1B, transcript variant X8
GRAM domain containing 1B, transcript variant X1
GRAM domain containing 1B, transcript variant X14
GRAM domain containing 1B, transcript variant X12
GRAM domain containing 1B, transcript variant X15
GRAM domain containing 1B, transcript variant X16
GRAM domain containing 1B, transcript variant X10
GRAM domain containing 1B, transcript variant X9
GRAM domain containing 1B, transcript variant X13
GRAM domain containing 1B, transcript variant X11
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
LOW QUALITY PROTEIN: CXADR-like membrane protein
heat shock protein family A (Hsp70) member 8
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00016
uncharacterized LOC125338368, transcript variant X2
uncharacterized LOC125338368, transcript variant X1
cytotoxic and regulatory T cell molecule
cytotoxic and regulatory T-cell molecule
ubiquitin associated and SH3 domain containing B, transcript variant X1
ubiquitin associated and SH3 domain containing B, transcript variant X2
ubiquitin-associated and SH3 domain-containing protein B isoform X1
ubiquitin-associated and SH3 domain-containing protein B isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
uncharacterized LOC125338196, transcript variant X2
uncharacterized LOC125338196, transcript variant X1
uncharacterized LOC125338196, transcript variant X5
uncharacterized LOC125338196, transcript variant X4
uncharacterized LOC125338196, transcript variant X3
sortilin related receptor 1, transcript variant X1
sortilin related receptor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
tubulin folding cofactor E like, transcript variant X1
tubulin folding cofactor E like, transcript variant X2
tubulin folding cofactor E like, transcript variant X4
tubulin folding cofactor E like, transcript variant X3
tubulin-specific chaperone cofactor E-like protein
glutamate ionotropic receptor kainate type subunit 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 106 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glutamate receptor ionotropic, kainate 4
Rho guanine nucleotide exchange factor 12, transcript variant X2
Rho guanine nucleotide exchange factor 12, transcript variant X1
rho guanine nucleotide exchange factor 12 isoform X2
rho guanine nucleotide exchange factor 12 isoform X1
TLC domain-containing protein 5-like, transcript variant X4
TLC domain-containing protein 5-like, transcript variant X3
TLC domain-containing protein 5-like, transcript variant X2
TLC domain-containing protein 5-like, transcript variant X1
TLC domain-containing protein 5-like, transcript variant X5
POU class 2 homeobox 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
POU class 2 homeobox 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
POU domain, class 2, transcription factor 3 isoform X2
POU domain, class 2, transcription factor 3 isoform X1
tripartite motif containing 29, transcript variant X2
tripartite motif containing 29, transcript variant X5
tripartite motif containing 29, transcript variant X3
tripartite motif containing 29, transcript variant X4
tripartite motif containing 29, transcript variant X1
tripartite motif-containing protein 29 isoform X1
tripartite motif-containing protein 29 isoform X2
tripartite motif-containing protein 29 isoform X5
tripartite motif-containing protein 29 isoform X3
tripartite motif-containing protein 29 isoform X4
nectin cell adhesion molecule 1, transcript variant X1
nectin cell adhesion molecule 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
nectin cell adhesion molecule 1, transcript variant X2
nectin cell adhesion molecule 1, transcript variant X5
nectin cell adhesion molecule 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
nectin cell adhesion molecule 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
nectin cell adhesion molecule 1, transcript variant X4
ubiquitin specific peptidase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 2 isoform X1
ubiquitin specific peptidase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 2 isoform X2
complement C1q tumor necrosis factor-related protein 5
melanoma cell adhesion molecule, transcript variant X1
melanoma cell adhesion molecule, transcript variant X2
cell surface glycoprotein MUC18 isoform X1
cell surface glycoprotein MUC18 isoform X2
Na(+)/H(+) exchange regulatory cofactor NHE-RF4
NLR family member X1, transcript variant X2
NLR family member X1, transcript variant X1
ATP binding cassette subfamily G member 4, transcript variant X1
ATP binding cassette subfamily G member 4, transcript variant X2
ATP-binding cassette sub-family G member 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
POU class 2 homeobox associating factor 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 62% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C11orf53 homolog
POU class 2 homeobox associating factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
POU class 2 homeobox associating factor 1, transcript variant X1
POU domain class 2-associating factor 1 isoform X1
POU class 2 homeobox associating factor 1, transcript variant X3
POU domain class 2-associating factor 1 isoform X2
uncharacterized LOC125338330, transcript variant X4
uncharacterized LOC125338330, transcript variant X5
uncharacterized LOC125338330, transcript variant X1
uncharacterized LOC125338330, transcript variant X3
uncharacterized LOC125338330, transcript variant X6
uncharacterized LOC125338330, transcript variant X7
uncharacterized LOC125338330, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC125338330, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized protein LOC125338330 isoform X2
uncharacterized protein LOC125338330 isoform X3
uncharacterized protein LOC125338330 isoform X4
uncharacterized protein LOC125338330 isoform X1
uncharacterized protein LOC125338330 isoform X5
uncharacterized protein LOC125338330 isoform X6
uncharacterized protein LOC125338330 isoform X8
uncharacterized LOC125338330, transcript variant X8
uncharacterized protein LOC125338330 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
salt inducible kinase 2, transcript variant X3
salt inducible kinase 2, transcript variant X1
salt inducible kinase 2, transcript variant X2
serine/threonine-protein kinase SIK2 isoform X1
serine/threonine-protein kinase SIK2 isoform X2
salt inducible kinase 2, transcript variant X4
serine/threonine-protein kinase SIK2 isoform X3
LOW QUALITY PROTEIN: alpha-1,2-mannosyltransferase ALG9
uncharacterized LOC125338231, transcript variant X1
ferredoxin-fold anticodon binding domain containing 1, transcript variant X2
ferredoxin-fold anticodon binding domain containing 1, transcript variant X1
ferredoxin-fold anticodon-binding domain-containing protein 1 isoform X2
ferredoxin-fold anticodon-binding domain-containing protein 1 isoform X1
uncharacterized LOC125338231, transcript variant X2
heat shock protein family B (small) member 2
uncharacterized protein C11orf52 homolog
DIX domain containing 1, transcript variant X2
DIX domain containing 1, transcript variant X1
DIX domain containing 1, transcript variant X3
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial
succinate dehydrogenase complex subunit D
succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: carotenoid-cleaving dioxygenase, mitochondrial
neural cell adhesion molecule 1, transcript variant X1
neural cell adhesion molecule 1, transcript variant X13
neural cell adhesion molecule 1, transcript variant X3
neural cell adhesion molecule 1, transcript variant X4
neural cell adhesion molecule 1, transcript variant X5
neural cell adhesion molecule 1, transcript variant X6
neural cell adhesion molecule 1, transcript variant X2
neural cell adhesion molecule 1, transcript variant X7
neural cell adhesion molecule 1, transcript variant X8
neural cell adhesion molecule 1, transcript variant X9
neural cell adhesion molecule 1, transcript variant X10
neural cell adhesion molecule 1, transcript variant X11
neural cell adhesion molecule 1, transcript variant X14
neural cell adhesion molecule 1, transcript variant X15
neural cell adhesion molecule 1, transcript variant X12
neural cell adhesion molecule 1 isoform X1
neural cell adhesion molecule 1 isoform X9
neural cell adhesion molecule 1 isoform X13
neural cell adhesion molecule 1 isoform X3
neural cell adhesion molecule 1 isoform X4
neural cell adhesion molecule 1 isoform X5
neural cell adhesion molecule 1 isoform X10
neural cell adhesion molecule 1 isoform X6
neural cell adhesion molecule 1 isoform X2
neural cell adhesion molecule 1 isoform X7
neural cell adhesion molecule 1 isoform X8
neural cell adhesion molecule 1 isoform X11
neural cell adhesion molecule 1 isoform X14
neural cell adhesion molecule 1 isoform X15
neural cell adhesion molecule 1 isoform X12
tetratricopeptide repeat domain 12, transcript variant X6
tetratricopeptide repeat domain 12, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
tetratricopeptide repeat domain 12, transcript variant X1
tetratricopeptide repeat domain 12, transcript variant X2
tetratricopeptide repeat domain 12, transcript variant X5
tetratricopeptide repeat domain 12, transcript variant X3
tetratricopeptide repeat domain 12, transcript variant X7
tetratricopeptide repeat domain 12, transcript variant X4
tetratricopeptide repeat domain 12, transcript variant X8
tetratricopeptide repeat domain 12, transcript variant X9
tetratricopeptide repeat protein 12 isoform X2
tetratricopeptide repeat protein 12 isoform X1
tetratricopeptide repeat protein 12 isoform X6
tetratricopeptide repeat protein 12 isoform X8
tetratricopeptide repeat protein 12 isoform X5
tetratricopeptide repeat protein 12 isoform X3
tetratricopeptide repeat protein 12 isoform X7
tetratricopeptide repeat protein 12 isoform X9
tetratricopeptide repeat protein 12 isoform X4
tetratricopeptide repeat protein 12 isoform X10
ankyrin repeat and kinase domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ankyrin repeat and protein kinase domain-containing protein 1
dopamine receptor D2, transcript variant X4
dopamine receptor D2, transcript variant X2
dopamine receptor D2, transcript variant X3
dopamine receptor D2, transcript variant X5
dopamine receptor D2, transcript variant X1
dopamine receptor D2, transcript variant X7
dopamine receptor D2, transcript variant X6
centromere/kinetochore protein zw10 homolog
T-cell surface glycoprotein CD3 gamma chain-like
T-cell surface glycoprotein CD3 epsilon chain, transcript variant X1
T-cell surface glycoprotein CD3 epsilon chain, transcript variant X2
T-cell surface glycoprotein CD3 epsilon chain, transcript variant X3
T-cell surface glycoprotein CD3 epsilon chain
junctional adhesion molecule-like, transcript variant X2
junctional adhesion molecule-like, transcript variant X1
junctional adhesion molecule-like isoform X1
junctional adhesion molecule-like isoform X2
microtubule-associated protein tau-like, transcript variant X2
microtubule-associated protein tau-like, transcript variant X1
microtubule-associated protein tau-like isoform X1
sodium voltage-gated channel beta subunit 2, transcript variant X1
sodium channel subunit beta-2 isoform X1
sodium voltage-gated channel beta subunit 2, transcript variant X2
sodium channel subunit beta-2 isoform X2
uncharacterized protein LOC125338310 isoform X2
sodium voltage-gated channel beta subunit 4, transcript variant X1
sodium channel subunit beta-4 isoform X1
sodium voltage-gated channel beta subunit 4, transcript variant X2
sodium channel subunit beta-4 isoform X2
sodium voltage-gated channel beta subunit 4, transcript variant X3
sodium channel subunit beta-4 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
FXYD domain containing ion transport regulator 6, transcript variant X1
FXYD domain containing ion transport regulator 6, transcript variant X2
FXYD domain-containing ion transport regulator 6
FXYD domain containing ion transport regulator 2, transcript variant X3
sodium/potassium-transporting ATPase subunit gamma isoform X3
FXYD domain containing ion transport regulator 2, transcript variant X1
sodium/potassium-transporting ATPase subunit gamma isoform X1
FXYD domain containing ion transport regulator 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
sodium/potassium-transporting ATPase subunit gamma isoform X2
DS cell adhesion molecule like 1, transcript variant X2
DS cell adhesion molecule like 1, transcript variant X1
DS cell adhesion molecule like 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein 1 isoform X2
Down syndrome cell adhesion molecule-like protein 1 isoform X1
Down syndrome cell adhesion molecule-like protein 1 isoform X4
DS cell adhesion molecule like 1, transcript variant X3
Down syndrome cell adhesion molecule-like protein 1 isoform X3
centrosomal protein 164, transcript variant X5
centrosomal protein 164, transcript variant X7
centrosomal protein 164, transcript variant X3
centrosomal protein 164, transcript variant X9
centrosomal protein 164, transcript variant X8
centrosomal protein 164, transcript variant X2
centrosomal protein 164, transcript variant X4
centrosomal protein 164, transcript variant X1
centrosomal protein of 164 kDa isoform X5
centrosomal protein of 164 kDa isoform X4
centrosomal protein of 164 kDa isoform X2
centrosomal protein of 164 kDa isoform X3
centrosomal protein of 164 kDa isoform X1
centrosomal protein 164, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ring finger protein 214, transcript variant X2
ring finger protein 214, transcript variant X1
proprotein convertase subtilisin/kexin type 7, transcript variant X2
proprotein convertase subtilisin/kexin type 7, transcript variant X1
proprotein convertase subtilisin/kexin type 7, transcript variant X3
proprotein convertase subtilisin/kexin type 7
SID1 transmembrane family member 2, transcript variant X4
SID1 transmembrane family member 2, transcript variant X2
SID1 transmembrane family member 2, transcript variant X3
SID1 transmembrane family member 2, transcript variant X5
SID1 transmembrane family member 2, transcript variant X1
SID1 transmembrane family member 2 isoform X4
SID1 transmembrane family member 2 isoform X2
SID1 transmembrane family member 2 isoform X3
SID1 transmembrane family member 2 isoform X1
SID1 transmembrane family member 2 isoform X5
SID1 transmembrane family member 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
SID1 transmembrane family member 2 isoform X6
SID1 transmembrane family member 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
SID1 transmembrane family member 2 isoform X7
platelet activating factor acetylhydrolase 1b catalytic subunit 2, transcript variant X2
platelet activating factor acetylhydrolase 1b catalytic subunit 2, transcript variant X1
platelet-activating factor acetylhydrolase IB subunit alpha2 isoform X1
platelet-activating factor acetylhydrolase IB subunit alpha2 isoform X2
SIK family kinase 3, transcript variant X4
SIK family kinase 3, transcript variant X5
SIK family kinase 3, transcript variant X3
SIK family kinase 3, transcript variant X1
SIK family kinase 3, transcript variant X2
serine/threonine-protein kinase SIK3 isoform X1
serine/threonine-protein kinase SIK3 isoform X3
serine/threonine-protein kinase SIK3 isoform X2
serine/threonine-protein kinase SIK3 isoform X4
serine/threonine-protein kinase SIK3 isoform X5
apolipoprotein A4, transcript variant X2
apolipoprotein A4, transcript variant X1
apolipoprotein A5, transcript variant X2
apolipoprotein A5, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein ZPR1
cell adhesion molecule 1, transcript variant X1
cell adhesion molecule 1, transcript variant X4
cell adhesion molecule 1, transcript variant X2
cell adhesion molecule 1, transcript variant X6
cell adhesion molecule 1, transcript variant X8
cell adhesion molecule 1, transcript variant X3
cell adhesion molecule 1, transcript variant X7
cell adhesion molecule 1, transcript variant X5
cell adhesion molecule 1, transcript variant X9
cell adhesion molecule 1, transcript variant X10
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: nicotinamide N-methyltransferase
zinc finger and BTB domain containing 16
LOW QUALITY PROTEIN: zinc finger and BTB domain-containing protein 16
5-hydroxytryptamine receptor 3A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
5-hydroxytryptamine receptor 3A-like, transcript variant X2
5-hydroxytryptamine receptor 3A-like isoform X2
5-hydroxytryptamine receptor 3A-like isoform X1
ubiquitin specific peptidase 28, transcript variant X1
ubiquitin specific peptidase 28, transcript variant X3
ubiquitin specific peptidase 28, transcript variant X4
ubiquitin specific peptidase 28, transcript variant X6
ubiquitin carboxyl-terminal hydrolase 28 isoform X1
ubiquitin carboxyl-terminal hydrolase 28 isoform X3
ubiquitin carboxyl-terminal hydrolase 28 isoform X4
ubiquitin carboxyl-terminal hydrolase 28 isoform X6
ubiquitin specific peptidase 28, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 28 isoform X2
ubiquitin specific peptidase 28, transcript variant X5
ubiquitin carboxyl-terminal hydrolase 28 isoform X5
ubiquitin specific peptidase 28, transcript variant X7
ubiquitin carboxyl-terminal hydrolase 28 isoform X7
G protein-activated inward rectifier potassium channel 4-like
lysine methyltransferase 2A, transcript variant X1
histone-lysine N-methyltransferase 2A isoform X1
lysine methyltransferase 2A, transcript variant X2
lysine methyltransferase 2A, transcript variant X3
histone-lysine N-methyltransferase 2A isoform X2
histone-lysine N-methyltransferase 2A isoform X3
intraflagellar transport protein 46 homolog
pleckstrin homology like domain family B member 1, transcript variant X11
pleckstrin homology like domain family B member 1, transcript variant X1
pleckstrin homology like domain family B member 1, transcript variant X2
pleckstrin homology like domain family B member 1, transcript variant X5
pleckstrin homology like domain family B member 1, transcript variant X6
pleckstrin homology like domain family B member 1, transcript variant X7
pleckstrin homology like domain family B member 1, transcript variant X8
pleckstrin homology like domain family B member 1, transcript variant X9
pleckstrin homology like domain family B member 1, transcript variant X10
pleckstrin homology-like domain family B member 1 isoform X2
pleckstrin homology-like domain family B member 1 isoform X6
pleckstrin homology-like domain family B member 1 isoform X5
pleckstrin homology-like domain family B member 1 isoform X7
pleckstrin homology-like domain family B member 1 isoform X1
pleckstrin homology-like domain family B member 1 isoform X8
pleckstrin homology-like domain family B member 1 isoform X9
pleckstrin homology-like domain family B member 1 isoform X10
pleckstrin homology like domain family B member 1, transcript variant X3
pleckstrin homology like domain family B member 1, transcript variant X4
pleckstrin homology-like domain family B member 1 isoform X3
pleckstrin homology-like domain family B member 1 isoform X4
pleckstrin homology-like domain family B member 1 isoform X11
solute carrier family 37 member 4, transcript variant X1
solute carrier family 37 member 4, transcript variant X2
glucose-6-phosphate exchanger SLC37A4 isoform X1
glucose-6-phosphate exchanger SLC37A4 isoform X2
trafficking protein particle complex subunit 4
centrosomal AT-AC splicing factor, transcript variant X1
centrosomal AT-AC splicing factor isoform X1
centrosomal AT-AC splicing factor, transcript variant X2
centrosomal AT-AC splicing factor, transcript variant X3
centrosomal AT-AC splicing factor isoform X2
B-cell CLL/lymphoma 9-like protein isoform X2
B-cell CLL/lymphoma 9-like protein isoform X1
DEAD-box helicase 6, transcript variant X1
DEAD-box helicase 6, transcript variant X2
probable ATP-dependent RNA helicase DDX6
VPS11 core subunit of CORVET and HOPS complexes
vacuolar protein sorting-associated protein 11 homolog
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: late histone H2A.L3
dolichyl-phosphate N-acetylglucosaminephosphotransferase 1
UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase
phospholipid transfer protein C2CD2L isoform X2
phospholipid transfer protein C2CD2L isoform X1